Hypercalcemia causes: Difference between revisions
No edit summary |
|||
Line 68: | Line 68: | ||
{| style="width:80%; height:100px" border="1" | {| style="width:80%; height:100px" border="1" | ||
| style="width:25%" bgcolor="LightSteelBlue" ; border="1" | '''Cardiovascular''' | | style="width:25%" bgcolor="LightSteelBlue" ; border="1" | '''Cardiovascular''' | ||
| style="width:75%" bgcolor="Beige" ; border="1" | [[Beuren- | | style="width:75%" bgcolor="Beige" ; border="1" | [[Beuren-Williams syndrome]], [[Vasoactive intestinal polypeptide-producing tumor]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Chemical / poisoning''' | | '''Chemical / poisoning''' | ||
| bgcolor="Beige" | [[Aluminium antacid overuse]], | | bgcolor="Beige" | [[Aluminium antacid overuse]], [[Aluminum intoxication]], [[Calcium acetate]], [[Caspofungin acetate]], [[Cefepime]], [[Chlortalidone]], [[Theophylline|Theophylline toxicity]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
| bgcolor="Beige" | [[Leprosy]], | | bgcolor="Beige" | [[Leprosy]], Subcutaneous fat necrosis of newborn | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
| bgcolor="Beige" | [[Cidofovir]], | | bgcolor="Beige" | [[Cidofovir]], [[Danazol]], [[Dexlansoprazole]], [[Diuretics]], [[Fluoxymesterone]], [[Gestrinone]], [[Lithium]], [[Nandrolone]], [[Paricalcitol]], [[Tamoxifen]], [[Teriparatide]], [[Thiazide]], [[Toremifene]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
Line 88: | Line 88: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
| bgcolor="Beige" | [[Abnormal parathyroid gland function]], | | bgcolor="Beige" | [[Abnormal parathyroid gland function]], [[Acromegaly]], [[Addison's disease]], [[Adenoma]], [[Adrenal cortex insufficiency]], [[Adrenal insufficiency]], [[Adult T-cell leukemia]], [[Bartter's syndrome]], [[Cushing's syndrome]], [[Familial hypocalciuric hypercalcemia]], [[Hyperparathyroidism|Familial isolated hyperparathyroidism]], [[Growth hormone secreting pituitary adenoma|Growth hormone-secreting pituitary adenoma]], Hypercalcemia of malignancy, [[Hyperparathyroidism]] , [[Hyperthyroidism]], [[Multiple endocrine neoplasia]], [[Hyperparathyroidism|Neonatal severe primary hyperparathyroidism]], [[Paget's disease of bone]], [[Parathyroid adenoma]], [[Parathyroid cancer|Parathyroid carcinoma]], Parathyroid hormone-related peptide, Parathyroid hyperplasia, [[Pituitary tumour ]] , Tryptophan malabsorption syndrome | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
Line 96: | Line 96: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
| bgcolor="Beige" | [[Hepatocellular carcinoma]], | | bgcolor="Beige" | [[Hepatocellular carcinoma]], [[Vipoma]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" | Activation of extra-renal 1 alpha-hydroxylase, [[Beuren-Williams syndrome]], [[Familial isolated hyperparathyroidism]], Metaphyseal chondrodysplasia, Phosphoethanolaminuria, Pseudophosphatasia, [[William's syndrome]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
| bgcolor="Beige" | [[Acute adult | | bgcolor="Beige" | [[Acute adult T-cell leukemia]], [[Adult T-cell leukemia]], [[Chronic adult T-cell leukemia]], Cuffed blood sample, [[Cushing's syndrome]], [[Familial hypocalciuric hypercalcemia]], [[Hematologic malignancy]], [[Hodgkin's lymphoma]], [[Hypervitaminosis A]], [[Hypervitaminosis D]], [[Hypokalaemic distal renal tubular acidosis]], [[Hypophosphataemia]], [[Hypophosphatasia]], [[Leukemia]], [[Lymphoma]], [[Multiple myeloma]], Plasma cell granuloma, [[Polycythemia]], Pseudophosphatasia, [[Adult T-cell leukemia|Smoldering adult T-cell leukemia]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
Line 112: | Line 112: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
| bgcolor="Beige" | [[Coccidioidomycosis]], | | bgcolor="Beige" | [[Coccidioidomycosis]], [[Histoplasmosis]], [[Oral candidiasis]], [[Tuberculosis]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal / Ortho''' | | '''Musculoskeletal / Ortho''' | ||
| bgcolor="Beige" | [[Bone cancer]], | | bgcolor="Beige" | [[Bone cancer]], [[Bone fracture]], Immobilization, Osteolytic bone metastases and local cytokines, [[Osteomalacia]], [[Osteoporosis]], [[Paget's disease of bone]], [[Paraplegia]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
| bgcolor="Beige" | [[Adrenal cortex insufficiency]], | | bgcolor="Beige" | [[Adrenal cortex insufficiency]], [[Brown-Sequard syndrome]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Nutritional / Metabolic''' | | '''Nutritional / Metabolic''' | ||
| bgcolor="Beige" | [[Milk-alkali syndrome]], | | bgcolor="Beige" | [[Milk-alkali syndrome]], [[Parenteral nutrition]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
| bgcolor="Beige" | [[Breast cancer]], | | bgcolor="Beige" | [[Breast cancer]], [[Ovarian cancer]], Subcutaneous fat necrosis of newborn | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
| bgcolor="Beige" | [[Acute adult | | bgcolor="Beige" | [[Acute adult T-cell leukemia]], [[Adenoma]], [[Adult T-cell leukemia]], [[Adult T-cell leukemia|Adult T-cell lymphoma]], [[Bone cancer]], [[Breast cancer]], [[Bronchial carcinoma]], [[Chronic adult T-cell leukemia]], [[Growth hormone secreting pituitary adenoma]], [[Hematologic malignancy]], [[Hepatocellular carcinoma]], [[Hodgkin's lymphoma]], Hypercalcemia of malignancy, [[Renal cancer]], [[Lymphoma]], [[Metastatic neoplasm]], [[Multiple endocrine neoplasia]], [[Multiple myeloma]], Osteolytic bone metastases and local cytokines, [[Osteomalacia]], [[Ovarian cancer]], [[Paraneoplastic syndrome]], [[Parathyroid adenoma]], [[Parathyroid carcinoma]], Parathyroid hyperplasia, [[Pheochromocytoma]], [[Pituitary tumor|Pituitary tumour]], Plasma cell granuloma, Silicone-induced granuloma, [[Adult T-cell leukemia|Smoldering adult T-cell leukemia]], [[Vasoactive intestinal polypeptide-producing tumor]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
Line 140: | Line 140: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Overdose / Toxicity''' | | '''Overdose / Toxicity''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" | [[Aluminum]] intoxication, [[Aspirin]] (in large amounts), [[Drugs]], [[Hypervitaminosis A]], [[Hypervitaminosis D]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
Line 148: | Line 148: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
| bgcolor="Beige" | [[Berylliosis]], | | bgcolor="Beige" | [[Berylliosis]], [[Bronchial carcinoma]], [[Coccidioidomycosis]], [[Histoplasmosis]], [[Sarcoidosis]], [[Tuberculosis]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Renal / Electrolyte''' | | '''Renal / Electrolyte''' | ||
| bgcolor="Beige" | [[Acute renal failure]], | | bgcolor="Beige" | [[Acute renal failure]], [[Bartter's syndrome]], [[Gitelman syndrome]], [[Hypokalaemic distal renal tubular acidosis]], [[Hypophosphataemia]], [[Hypophosphatasia]], [[Renal cancer]], [[Kidney transplant]], [[Milk-alkali syndrome]], [[Renal failure]], [[Rhabdomyolysis]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Rheum / Immune / Allergy''' | | '''Rheum / Immune / Allergy''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" | Chronic granulomatous disorders, [[Sarcoidosis]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
Line 164: | Line 164: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Trauma''' | | '''Trauma''' | ||
| bgcolor="Beige" | [[Bone fracture]], | | bgcolor="Beige" | [[Bone fracture]], [[Dehydration]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" |
Revision as of 19:27, 7 June 2018
Hypercalcemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypercalcemia On the Web |
American Roentgen Ray Society Images of Hypercalcemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2], Luke Rusowicz-Orazem, B.S.
Overview
Hypercalcemia is most commonly caused by hyperparathyroisism and malignancy. Other causes of hypercalcemia include hyperthyroidism, vitamin D toxicity, increased calcium intake, granulomatous diseases ( such sarcoidosis), and various renal disorders.
Causes
Life-Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Severity of hypercalcemia is more related to life-threatening situations rather that particular cause.
Common Causes
Common causes of hypercalcemia include:[1]
- Hyperparathyroidism[2][3]
- Hypercalcemia of malignancy[7][8]
- Hyperthyroidism[9][10]
- Hypervitaminosis D[11][12][13]
- Chronic kidney disease[14]
- Milk-alkali syndrome
- Hypokalaemic distal renal tubular acidosis
- Sarcoidosis[15][16]
- Post renal transplantation
Less Common Cause
Less common causes of hypercalcemia include:[1]
- Immobilization
- Pagets disease of bone
- Hypervitaminosis A
- Pheochromocytoma
- Adrenal insufficiency
- Rhabdomyolysis
- Acute renal failure
- Familial hypocalciuric hypercalcemia[17]
- Methphysial chondrodysplasia
- Conenital lactase deficienccy
- Idiopathic infantile hypercalcemia (Williams syndrome)
- Mutations of the calcium-sensing receptor
- Subcutaneous fat necrosis
- Blue diaper syndrome
- Hypophosphataemia
- Hypophosphatasia
- Dietary phosphate deficiency
- Medication-induced
- Lithium[18]
- Thiazide[19]
- Theophylline toxicity
- Teriparatide
- Estrogen
- Cidofovir
- Danazol
- Dexlansoprazole
- Fluoxymesterone
- Gestrinone
- Nandrolone
- Paricalcitol
- Tamoxifen
- Toremifene
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ 1.0 1.1 Carroll R, Matfin G (2010). "Endocrine and metabolic emergencies: hypercalcaemia". Ther Adv Endocrinol Metab. 1 (5): 225–34. doi:10.1177/2042018810390260. PMC 3474617. PMID 23148166.
- ↑ Peacock M (2002). "Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum". J. Bone Miner. Res. 17 Suppl 2: N87–94. PMID 12412783.
- ↑ Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV (1989). "Skeletal disease in primary hyperparathyroidism". J. Bone Miner. Res. 4 (3): 283–91. doi:10.1002/jbmr.5650040302. PMID 2763869.
- ↑ Wieneke JA, Smith A (2008). "Parathyroid adenoma". Head Neck Pathol. 2 (4): 305–8. doi:10.1007/s12105-008-0088-8. PMC 2807581. PMID 20614300.
- ↑ Rodriguez M, Nemeth E, Martin D (2005). "The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism". Am J Physiol Renal Physiol. 288 (2): F253–64. doi:10.1152/ajprenal.00302.2004. PMID 15507543.
- ↑ Kilgo MS, Pirsch JD, Warner TF, Starling JR (1998). "Tertiary hyperparathyroidism after renal transplantation: surgical strategy". Surgery. 124 (4): 677–83, discussion 683–4. doi:10.1067/msy.1998.91483. PMID 9780988.
- ↑ Mirrakhimov AE (2015). "Hypercalcemia of Malignancy: An Update on Pathogenesis and Management". N Am J Med Sci. 7 (11): 483–93. doi:10.4103/1947-2714.170600. PMC 4683803. PMID 26713296.
- ↑ Stewart AF (2005). "Clinical practice. Hypercalcemia associated with cancer". N Engl J Med. 352 (4): 373–9. doi:10.1056/NEJMcp042806. PMID 15673803.
- ↑ Burman KD, Monchik JM, Earll JM, Wartofsky L (1976). "Ionized and total serum calcium and parathyroid hormone in hyperthyroidism". Ann Intern Med. 84 (6): 668–71. PMID 937877.
- ↑ Iqbal AA, Burgess EH, Gallina DL, Nanes MS, Cook CB (2003). "Hypercalcemia in hyperthyroidism: patterns of serum calcium, parathyroid hormone, and 1,25-dihydroxyvitamin D3 levels during management of thyrotoxicosis". Endocr Pract. 9 (6): 517–21. doi:10.4158/EP.9.6.517. PMID 14715479.
- ↑ Hoeck HC, Laurberg G, Laurberg P (1994). "Hypercalcaemic crisis after excessive topical use of a vitamin D derivative". J. Intern. Med. 235 (3): 281–2. PMID 8120527.
- ↑ Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GE, Seely EW (1992). "Hypervitaminosis D associated with drinking milk". N. Engl. J. Med. 326 (18): 1173–7. doi:10.1056/NEJM199204303261801. PMID 1313547.
- ↑ Sharma OP (1996). "Vitamin D, calcium, and sarcoidosis". Chest. 109 (2): 535–9. PMID 8620732.
- ↑ Meric F, Yap P, Bia MJ (1990). "Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy". Am J Kidney Dis. 16 (5): 459–64. PMID 2239937.
- ↑ Dusso AS, Kamimura S, Gallieni M, Zhong M, Negrea L, Shapiro S, Slatopolsky E (1997). "gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses". J. Clin. Endocrinol. Metab. 82 (7): 2222–32. doi:10.1210/jcem.82.7.4074. PMID 9215298.
- ↑ Vanstone MB, Oberfield SE, Shader L, Ardeshirpour L, Carpenter TO (2012). "Hypercalcemia in children receiving pharmacologic doses of vitamin D." Pediatrics. 129 (4): e1060–3. doi:10.1542/peds.2011-1663. PMID 22412034.
- ↑ Vargas-Poussou R, Mansour-Hendili L, Baron S, Bertocchio JP, Travers C, Simian C; et al. (2016). "Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences". J Clin Endocrinol Metab. 101 (5): 2185–95. doi:10.1210/jc.2015-3442. PMID 26963950.
- ↑ Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S (1989). "Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume". J. Clin. Endocrinol. Metab. 68 (3): 654–60. doi:10.1210/jcem-68-3-654. PMID 2918061.
- ↑ Griebeler ML, Kearns AE, Ryu E, Thapa P, Hathcock MA, Melton LJ; et al. (2016). "Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades". J Clin Endocrinol Metab. 101 (3): 1166–73. doi:10.1210/jc.2015-3964. PMC 4803175. PMID 26751196.